Lennar Corp (LEN) 47.19 $LEN Final Glance: Homebuilders

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lennar Corp (LEN) 47.19 $LEN

Final Glance: Homebuilders companies
AP - Fri Apr 24, 7:08PM CDT
NEW YORK (AP) — Shares of some top homebuilders companies were up at the close of trading:
LEN: 47.19 (+0.47), LEN.B: 37.63 (+0.46), HOV: 3.20 (unch)

Midday Glance: Homebuilders companies
AP - Fri Apr 24, 12:36PM CDT
NEW YORK (AP) — Shares of some top homebuilders companies are mixed at 1 p.m.:
LEN: 47.19 (+0.47), LEN.B: 37.63 (+0.46), HOV: 3.20 (unch)

Early Glance: Homebuilders companies
AP - Fri Apr 24, 9:55AM CDT
NEW YORK (AP) — Shares of some top homebuilders companies are up at 10 a.m.:
LEN: 47.19 (+0.47), LEN.B: 37.63 (+0.46), HOV: 3.20 (unch)

March Existing Home Sales: More Sizzle Than Substance
Dave Kranzler - at Seeking Alpha - Fri Apr 24, 1:18AM CDT

DHI: 26.57 (+0.42), LEN: 47.19 (+0.47), RYL: 45.19 (+0.80), PHM: 20.12 (+0.15), BZH: 17.69 (+0.35), KBH: 14.88 (+0.11), TOL: 36.80 (+0.75)

After Yesterday's Decline of 3.49%, Lennar Offers Investors Better Value
Comtex SmarTrend(R) - Thu Apr 23, 4:06PM CDT
Lennar (NYSE:LEN) traded in a range yesterday that spanned from a low of $46.18 to a high of $48.06. Yesterday, the shares fell 3.5%, which took the trading range below the 3-day low of $47.71 on volume of 7.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
LEN: 47.19 (+0.47)

Look for Shares of Lennar to Potentially Rebound after Yesterday's 3.49% Sell Off
Comtex SmarTrend(R) - Thu Apr 23, 4:05PM CDT
Lennar (NYSE:LEN) traded in a range yesterday that spanned from a low of $46.18 to a high of $48.06. Yesterday, the shares fell 3.5%, which took the trading range below the 3-day low of $47.71 on volume of 7.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
LEN: 47.19 (+0.47)

Crude Oil Rally Pushes Nasdaq to All-Time Closing High
at The Street - Thu Apr 23, 3:32PM CDT
Crude oil pushes the Nasdaq to an all-time record close.
MMM: 158.99 (-0.67), GMCR: 115.05 (+1.50), XOM: 86.97 (-0.57), HOV: 3.20 (unch), PEP: 95.17 (-0.56), SJM: 116.31 (-0.66), SBUX: 51.84 (+2.41), T: 34.01 (-0.22), DNKN: 54.03 (+2.52), EBAY: 59.20 (+0.31), XHB: 35.95 (+0.60), QCOM: 68.24 (-0.10), GOOGL: 573.66 (+16.20), BP: 43.46 (-0.14), TWC: 155.26 (+6.50), CAT: 84.60 (-0.19), KBH: 14.88 (+0.11), MSFT: 47.87 (+4.53), XLE: 81.98 (-0.47), AMZN: 445.10 (+55.11), FB: 81.53 (-0.88), UAL: 63.51 (+0.71), LEN: 47.19 (+0.47), RDS.A: 62.76 (-0.20), GM: 35.59 (-0.33), PG: 81.00 (+0.05), CVX: 109.87 (-0.10), CMCSA: 59.64 (+0.41), TOL: 36.80 (+0.75)

Stocks Slip From Highs, Crude Oil Closes Above $57
at The Street - Thu Apr 23, 1:54PM CDT
Stocks slip slightly from session highs on Thursday afternoon, though the S&P 500 and Nasdaq remain within reach of all-time highs
MMM: 158.99 (-0.67), GMCR: 115.05 (+1.50), XOM: 86.97 (-0.57), HOV: 3.20 (unch), PEP: 95.17 (-0.56), SJM: 116.31 (-0.66), T: 34.01 (-0.22), DNKN: 54.03 (+2.52), EBAY: 59.20 (+0.31), XHB: 35.95 (+0.60), QCOM: 68.24 (-0.10), BP: 43.46 (-0.14), CAT: 84.60 (-0.19), KBH: 14.88 (+0.11), XLE: 81.98 (-0.47), FB: 81.53 (-0.88), UAL: 63.51 (+0.71), LEN: 47.19 (+0.47), RDS.A: 62.76 (-0.20), GM: 35.59 (-0.33), PG: 81.00 (+0.05), CVX: 109.87 (-0.10), TOL: 36.80 (+0.75)

PulteGroup Plummets As Q1 Costs, Construction Hit EPS
at Investor's Business Daily - Thu Apr 23, 1:00PM CDT
Shares of homebuilder PulteGroup (PHM) on Thursday sank to their lowest level since November after the company reported first-quarter results that missed views due to fewer closings in what its CEO called "a sustained but slow recovery" in the...
DHI: 26.57 (+0.42), LEN: 47.19 (+0.47), PHM: 20.12 (+0.15)

New Home-Sales Crater But Also Point To Future Growth
at Investor's Business Daily - Thu Apr 23, 12:29PM CDT
Sales of new homes came in at an annual pace of 481,000 units in March -- hardly the 518,000 that economists had been expecting. That represented an 11.4% drop from February. But there were some important caveats. February's read of 543,000 newly...
DHI: 26.57 (+0.42), LEN: 47.19 (+0.47), PHM: 20.12 (+0.15), KBH: 14.88 (+0.11)

Stocks Stage Bullish Reversal; Apparel Sector Shows Strength
at Investor's Business Daily - Thu Apr 23, 12:18PM CDT
For the second session in a row, the major stock indexes on Thursday bounced off morning lows in a bullish positive reversal. Two days aren't enough to make a trend, but positive reversals are a sign of strength. In early afternoon trade, the Nasdaq...
SBUX: 51.84 (+2.41), TSCO: 90.98 (-0.28), UA: 82.56 (-0.70), LEN: 47.19 (+0.47), SKX: 89.66 (+2.79), PHM: 20.12 (+0.15), DECK: 75.06 (-0.56), TOL: 36.80 (+0.75)

Sector Snap: Homebuilders drop as March new home sales slide
AP - Thu Apr 23, 11:44AM CDT
NEW YORK (AP) — Shares of homebuilders fell Thursday after a government report showed that sales of new homes slumped in March.
LEN: 47.19 (+0.47), RYL: 45.19 (+0.80), MDC: 27.53 (+0.52), SPF: 8.25 (+0.30), LEN.B: 37.63 (+0.46), BZH: 17.69 (+0.35), KBH: 14.88 (+0.11), TOL: 36.80 (+0.75), HOV: 3.20 (unch), MTH: 45.40 (+1.45)

Stocks Are Lower as Disappointing Earnings Dominate Markets
at The Street - Thu Apr 23, 10:24AM CDT
Stocks slide as homebuilders tumble on weak new home sales in March.
MMM: 158.99 (-0.67), FB: 81.53 (-0.88), GMCR: 115.05 (+1.50), HOV: 3.20 (unch), UAL: 63.51 (+0.71), SJM: 116.31 (-0.66), PEP: 95.17 (-0.56), T: 34.01 (-0.22), DNKN: 54.03 (+2.52), LEN: 47.19 (+0.47), EBAY: 59.20 (+0.31), XHB: 35.95 (+0.60), QCOM: 68.24 (-0.10), PHM: 20.12 (+0.15), GM: 35.59 (-0.33), CAT: 84.60 (-0.19), PG: 81.00 (+0.05), KBH: 14.88 (+0.11), TOL: 36.80 (+0.75)

PulteGroup earnings, soft new home sales lead homebuilders lower
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 9:17AM CDT

DHI: 26.57 (+0.42), LEN: 47.19 (+0.47), RYL: 45.19 (+0.80), SPF: 8.25 (+0.30), BZH: 17.69 (+0.35), KBH: 14.88 (+0.11), HOV: 3.20 (unch), TOL: 36.80 (+0.75)

D.R. Horton's Q2 Earnings Beat, But Margins Shrink
at Investor's Business Daily - Wed Apr 22, 1:24PM CDT
D.R. Horton's (DHI) fiscal second-quarter earnings topped analysts' forecasts, but gross margins fell and sales of higher-end homes were weaker. The homebuilder said on its earnings call Wednesday that gains in its upscale Emerald Homes have been...
DHI: 26.57 (+0.42), MHO: 23.59 (+0.38), LEN: 47.19 (+0.47), PHM: 20.12 (+0.15), KBH: 14.88 (+0.11)

Existing-Home Sales Surge 6%, But Homebuilders Fall
at Investor's Business Daily - Wed Apr 22, 1:24PM CDT
Call it a spring comeback for housing? Existing-home sales leapt to the fastest rate in 18 months in March. The annual rate of 5.19 million beat expectations and marked the sixth-straight month of annual increases. In March, that was a 10.4% gain vs....
DHI: 26.57 (+0.42), LEN: 47.19 (+0.47), PHM: 20.12 (+0.15), KBH: 14.88 (+0.11), NVR: 1,345.10 (+24.10)

Homebuilders decline as D.R. Horton cuts margin guidance
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 9:52AM CDT

LEN: 47.19 (+0.47), RYL: 45.19 (+0.80), XHB: 35.95 (+0.60), SPF: 8.25 (+0.30), ITB: 26.98 (+0.31), PHM: 20.12 (+0.15), KBH: 14.88 (+0.11), TOL: 36.80 (+0.75)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 487

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 513

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Laboratoires Pierre Fabre and XtalPi Unite for AI-Driven Drug Hunt

Updated Category News Views 46

An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 189

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Updated Category News Views 202

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 347

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

Updated Category News Views 56

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Continue Reading
AWS Boosts Agilix's AI Education in Sierra Leone

Updated Category News Views 62

Agilix Labs' Landmark Leap with AWS Just when you think you've got the grip on global education dynamics, a new wave hits your shores, this time courtesy of Agilix Labs and AWS. Agilix Labs snagged a grant from Amazon Web Services, carving a path that blends AI with educational equity in Sierra Leone. Now, if that doesn’t prick up investor ears or yank a few...

Continue Reading
Niagara Networks Boosts TLS 1.3 Decryption to 90+ Gbps

Updated Category News Views 95

In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 345

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading

Top 5 Most Recently Viewed Articles

EssilorLuxottica Reports Share Capital and Voting Rights Update

Updated Category News Views 214

Overview of EssilorLuxottica's Share Capital EssilorLuxottica, a prominent global leader in eyewear design, manufacture, and distribution, provides a detailed disclosure of its outstanding share capital and voting rights as of a recent date. This information is essential for shareholders and market watchers to understand the company's governance and share structure. Share...

Continue Reading
WM Technology, Inc. Faces Class Action Lawsuit with SEC Fallout

Updated Category News Views 208

WM Technology, Inc. Faces Legal Challenges Recently, a class action lawsuit has arisen against WM Technology, Inc. (NASDAQ: MAPS), a pivotal player in the online cannabis marketplace. The Pomerantz Law Firm has initiated this legal action on behalf of affected investors. As the case unfolds, individuals who believe they have been impacted by the company's actions are...

Continue Reading
EVgo Targets 2026 for Profitable Future Amid Challenges

Updated Category News Views 554

EVgo Overview EVgo Inc. (NASDAQ: EVGO) has faced recent fluctuations in share price following the announcement of its fiscal third-quarter results. The company operates one of the largest public electric vehicle charging networks in the United States, and it has been navigating a challenging landscape in the EV sector. Financial Performance Analysis In its latest report,...

Continue Reading
CNX Resources Corporation Reveals Financial Updates and Call Schedule

Updated Category News Views 126

CNX Resources Corporation Financial Results Announcement CNX Resources Corporation (NYSE: CNX) is set to unveil its financial results for the fourth quarter of 2025. This important event will take place at 6:45 a.m. Eastern Time on an upcoming Thursday. During this announcement, CNX intends to release a concise press statement that will include essential documents linking...

Continue Reading
Nvidia's Revolutionary AI Dominance and Future Outlook

Updated Category News Views 193

Understanding AI and Nvidia's Impact Since the dawn of the internet, investors have seen many trends come and go, but few have been as impactful as the artificial intelligence (AI) revolution. This groundbreaking technology has sparked interest among both seasoned professionals and everyday investors, all eager to explore its immense potential. It’s estimated that AI...

Continue Reading